| 注册
首页|期刊导航|中国药房|老年人跌倒的药物相关风险因素的范围综述

老年人跌倒的药物相关风险因素的范围综述

覃丽宇 龙绪峰 曹宏雅 梁珂源 黄明媚 张宏亮

中国药房2026,Vol.37Issue(7):960-964,5.
中国药房2026,Vol.37Issue(7):960-964,5.DOI:10.6039/j.issn.1001-0408.2026.07.23

老年人跌倒的药物相关风险因素的范围综述

Scoping review of medication-related risk factors for falls in older adults

覃丽宇 1龙绪峰 1曹宏雅 1梁珂源 1黄明媚 1张宏亮1

作者信息

  • 1. 广西医科大学第一附属医院药学部,南宁 530021
  • 折叠

摘要

Abstract

OBJECTIVE To systematically review medication-related risk factors for falls in older adults,to provide references for ensuring medication safety among older adults.METHODS A systematic search was conducted in PubMed,Embase,Web of Science,and CNKI for relevant literature published from database inception to November 1,2025.Relevant studies on medication-related falls in older adults,both domestic and international,were included.Drug factors influencing falls in older adults were summarized and analyzed.RESULTS A total of 22 studies were included.Four major classes of fall-risk-increasing drugs were identified:psychotropic medications[12 studies,odds ratio(OR)range 1.500-5.790],cardiovascular system drugs(5 studies,OR range 1.236-4.784),analgesics(3 studies,OR range 1.500-4.490),and hypoglycemic agents(3 studies,OR range 2.070-2.751).Additionally,anticholinergic burden(1 study,OR was 2.610)and polypharmacy(7 studies,OR range 2.902-25.897 for the use of≥4 medications)were identified as significant risk factors for falls.CONCLUSIONS Falls in older adults are significantly associated with psychotropic medications,cardiovascular system drugs,analgesics,and hypoglycemic agents,among which psychotropic medications pose the highest risk.Anticholinergic burden and polypharmacy are also important risk factors.In clinical practice,interventions should be implemented through deprescribing and risk monitoring to effectively reduce the risk of falls in older adults.

关键词

老年人/跌倒/风险因素/多重用药/范围综述

Key words

older adults/falls/risk factors/polypharmacy/scoping review

分类

医药卫生

引用本文复制引用

覃丽宇,龙绪峰,曹宏雅,梁珂源,黄明媚,张宏亮..老年人跌倒的药物相关风险因素的范围综述[J].中国药房,2026,37(7):960-964,5.

基金项目

国家卫生健康委医院管理研究所医疗质量(循证)管理研究项目(No.YLZLXZ23K004) (循证)

中国药房

1001-0408

访问量0
|
下载量0
段落导航相关论文